Coca-Cola (KO): FY24 Q4 earnings call, Feb 11, 2025

Tue, Feb 11Earnings callSpeaker-labelled transcriptCoca-Cola

No Kalshi or Polymarket word markets were listed for Coca-Cola’s Feb 11, 2025 earnings call (FY24 Q4). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

4 matches for “GLP-1”; 3 quoted, at least 25 words apart.

Bonnie Herzoganalystqa

…lately, but how are you thinking about potential impacts on consumption from GLP-1 drugs. Have you seen any impact? And has your thinking on this…

James Quinceycompanyqa

…we will adapt as and when they come. More specifically on the GLP-1s as we've commented on previous calls, we continue to see anecdotal evidence…

James Quinceycompanyqa

…and we are a total beverage company. So we believe whether it's GLP-1 drugs or changes and adaptations to regulation ingredients, our objective is to…

Agents: this page as TSV at /api/v1/appearances/coca-cola:2025-02-11:earnings_call · words: /api/v1/brief?appearance=coca-cola:2025-02-11:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP